Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Mesenchymal Stem Cell Conditioned Medium for Cancer Cachexia and Cancer Therapy Side Effects
jRCT1051250195Recruiting
- Sponsor
- Medical Clinic Ginza
- Start
- Dec 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer anorexia-cachexia syndrome (CACS), Adverse effects of anticancer therapy (AEs) and cancer, sponsored by Medical Clinic Ginza. Primary endpoints: Change in clinical condition at 1 month, Change in blood parameters (CBC, tumor markers, hs-CRP) at 1 month and 1 more. Started Dec 2025; status: recruiting.
02
Conditions
cancer anorexia-cachexia syndrome (CACS)Adverse effects of anticancer therapy (AEs)cancer
Beyond the preview
Go deeper on jRCT1051250195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250195.